Tatva Chintan Pharma Chem Limited (TATVA.NS)
- Previous Close
769.00 - Open
770.00 - Bid 775.50 x --
- Ask 775.85 x --
- Day's Range
753.05 - 779.00 - 52 Week Range
621.00 - 1,222.00 - Volume
47,407 - Avg. Volume
58,394 - Market Cap (intraday)
18.161B - Beta (5Y Monthly) 0.05
- PE Ratio (TTM)
315.39 - EPS (TTM)
2.46 - Earnings Date May 2, 2025
- Forward Dividend & Yield 2.00 (0.26%)
- Ex-Dividend Date Sep 6, 2024
- 1y Target Est
1,024.00
Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical and agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. The company serves automotive, refinery, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
www.tatvachintan.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: TATVA.NS
View MorePerformance Overview: TATVA.NS
Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TATVA.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TATVA.NS
View MoreValuation Measures
Market Cap
18.00B
Enterprise Value
18.21B
Trailing P/E
315.16
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.70
Price/Book (mrq)
2.43
Enterprise Value/Revenue
4.76
Enterprise Value/EBITDA
49.86
Financial Highlights
Profitability and Income Statement
Profit Margin
1.49%
Return on Assets (ttm)
0.49%
Return on Equity (ttm)
0.77%
Revenue (ttm)
3.83B
Net Income Avi to Common (ttm)
57.13M
Diluted EPS (ttm)
2.46
Balance Sheet and Cash Flow
Total Cash (mrq)
140.96M
Total Debt/Equity (mrq)
4.93%
Levered Free Cash Flow (ttm)
-506.26M